Theravance Biopharma
Aug 17, 2020
New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves
The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019 and is anticipated to increase at a CAGR for the study period 2017-2030 owing to dynamic pipeline therapies in the mid-/ late-stage clinical development and rising gastroparesis prevalence. Gastroparesis or Delayed gastric emp...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
